| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |